Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
Go back to Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance| AbbVie (NYSE: ABBV) | Delayed: 256.03 +2.73 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.30 | 52 Week High | $68.12 | |||
| Open | $253.98 | 52 Week Low | $50.71 | |||
| Day High | $258.38 | P/E | 55.54 | |||
| Day Low | $253.10 | EPS | $4.61 | |||
| Volume | 1,946,368 | |||||
